Literature DB >> 19583557

RAPID3-an index of physical function, pain, and global status as "vital signs" to improve care for people with chronic rheumatic diseases.

Theodore Pincus1, Martin J Bergman, Yusuf Yazici.   

Abstract

A guide to RAPID3 (routine assessment of patient index data), an index of three patient self-report measures-physical function, pain, and patient global estimate of status-on a multidimensional health assessment questionnaire (MDAQ) is presented, including development, scoring, use in standard care, and rationale. RAPID3 and its individual components are regarded as "vital signs," which may alert a health professional to unsuspected patient problems, provide a baseline measure to support a change in therapy, and numerically document improvement or worsening over time to complement clinical impressions. MDHAQ-RAPID3 can be incorporated into the infrastructure of standard rheumatology care for completion in the waiting room by every patient with any rheumatic disease at every visit: if there is a reason for a visit, there is a reason for RAPID3 vital signs. RAPID3 is calculated in 5 to 10 seconds, providing similar information to DAS28 (disease activity score) and CDAI (clinical disease activity index), which require a mean of 114 and 106 seconds, respectively. MDHAQ-RAPID3 presents an additional advantage for the patient to optimize the office encounter by completion of the questionnaire in the waiting room. The MDHAQ also includes a review of systems and recent medical history, which can save 2 to 3 minutes per visit for other patient concerns. A physician's clinical decisions ultimately require synthesis and interpretation of all available data, ranging from laboratory tests to patient questionnaire scores. RAPID3 vital signs can contribute to this synthesis toward improved quality, outcomes, and documentation of rheumatology care.

Entities:  

Mesh:

Year:  2009        PMID: 19583557

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  14 in total

1.  Correlation between rapid-3, DAS28, CDAI and SDAI as a measure of disease activity in a cohort of Colombian patients with rheumatoid arthritis.

Authors:  Jesus Giovanny Ballesteros Muñoz; Rodrigo B Giraldo; Ana M Santos; Juan Manuel Bello-Gualteros; Juan C Rueda; Eugenia-Lucia Saldarriaga; Jose-Ignacio Angarita; Sofia Arias-Correal; Andres Y Vasquez; John Londono
Journal:  Clin Rheumatol       Date:  2016-12-24       Impact factor: 2.980

2.  Sexual function in Moroccan women with rheumatoid arthritis and its relationship with disease activity.

Authors:  Asmae Hari; Samira Rostom; Racha Lahlou; Rachid Bahiri; Najia Hajjaj-Hassouni
Journal:  Clin Rheumatol       Date:  2015-02-13       Impact factor: 2.980

3.  Arthroscopic synovectomy of the knee joint for rheumatoid arthritis.

Authors:  Marina Lipina; Maxim Makarov; Victor Mukhanov; Alexander Karpashevich; Sergey Maglevaniy; Vera Amirdjапоvа; Sergey Archipov
Journal:  Int Orthop       Date:  2018-10-03       Impact factor: 3.075

Review 4.  Advances in the treatment of inflammatory arthritis.

Authors:  David S Pisetsky; Michael M Ward
Journal:  Best Pract Res Clin Rheumatol       Date:  2012-04       Impact factor: 4.098

5.  Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis.

Authors:  Martin J Bergman; Eric P Elkin; Sarika Ogale; Tripthi Kamath; Max I Hamburger
Journal:  Rheumatol Ther       Date:  2014-09-23

6.  Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis.

Authors:  Isabel Castrejón; Theodore Pincus; Daniel Wendling; Maxime Dougados
Journal:  RMD Open       Date:  2016-07-07

7.  Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis.

Authors:  B Truong; N Rich-Garg; B D Ehst; A A Deodhar; J H Ku; K Vakil-Gilani; A Danve; A Blauvelt
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-11-04

8.  MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology care at four sites.

Authors:  Carlos El-Haddad; Isabel Castrejon; Kathryn A Gibson; Yusuf Yazici; Martin J Bergman; Theodore Pincus
Journal:  RMD Open       Date:  2017-07-18

9.  Efficacy of prednisone 1-4 mg/day in patients with rheumatoid arthritis: a randomised, double-blind, placebo controlled withdrawal clinical trial.

Authors:  T Pincus; C J Swearingen; G Luta; T Sokka
Journal:  Ann Rheum Dis       Date:  2008-12-15       Impact factor: 19.103

10.  Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.

Authors:  Sung-Hoon Park; Jung-Yoon Choe; Seong-Kyu Kim; Hwajeong Lee; Isabel Castrejón; Theodore Pincus
Journal:  J Clin Rheumatol       Date:  2015-09       Impact factor: 3.517

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.